Class I and III antiarrhythmic drugs: Practical considerations for safe, effective use

Arshad Jahangir, Marshall S. Stanton, Stephen C. Hammill, Win Kuang Shen

Research output: Contribution to journalArticle

Abstract

Pharmacologic therapy continues to play an important role in the management of cardiac arrhythmias. Choosing an antiarrhythmic agent involves understanding the concepts related to arrhythmogenesis, risk stratification of patients, and antiarrhythmic mechanisms as well as the pharmacokinetics and pharmacodynamics of individual antiarrhythmic agents. This review focuses on some practical issues related to antiarrhythmic pharmacologic therapy with individual class I and class III antiarrhythmic agents currently in clinical use in the United States.

Original languageEnglish (US)
Pages (from-to)534-557
Number of pages24
JournalFormulary
Volume33
Issue number6
StatePublished - 1998

Fingerprint

Anti-Arrhythmia Agents
Cardiac Arrhythmias
Pharmacokinetics
Therapeutics

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Jahangir, A., Stanton, M. S., Hammill, S. C., & Shen, W. K. (1998). Class I and III antiarrhythmic drugs: Practical considerations for safe, effective use. Formulary, 33(6), 534-557.

Class I and III antiarrhythmic drugs : Practical considerations for safe, effective use. / Jahangir, Arshad; Stanton, Marshall S.; Hammill, Stephen C.; Shen, Win Kuang.

In: Formulary, Vol. 33, No. 6, 1998, p. 534-557.

Research output: Contribution to journalArticle

Jahangir, A, Stanton, MS, Hammill, SC & Shen, WK 1998, 'Class I and III antiarrhythmic drugs: Practical considerations for safe, effective use', Formulary, vol. 33, no. 6, pp. 534-557.
Jahangir A, Stanton MS, Hammill SC, Shen WK. Class I and III antiarrhythmic drugs: Practical considerations for safe, effective use. Formulary. 1998;33(6):534-557.
Jahangir, Arshad ; Stanton, Marshall S. ; Hammill, Stephen C. ; Shen, Win Kuang. / Class I and III antiarrhythmic drugs : Practical considerations for safe, effective use. In: Formulary. 1998 ; Vol. 33, No. 6. pp. 534-557.
@article{5280f712337e42379dcc6fc3773f69a2,
title = "Class I and III antiarrhythmic drugs: Practical considerations for safe, effective use",
abstract = "Pharmacologic therapy continues to play an important role in the management of cardiac arrhythmias. Choosing an antiarrhythmic agent involves understanding the concepts related to arrhythmogenesis, risk stratification of patients, and antiarrhythmic mechanisms as well as the pharmacokinetics and pharmacodynamics of individual antiarrhythmic agents. This review focuses on some practical issues related to antiarrhythmic pharmacologic therapy with individual class I and class III antiarrhythmic agents currently in clinical use in the United States.",
author = "Arshad Jahangir and Stanton, {Marshall S.} and Hammill, {Stephen C.} and Shen, {Win Kuang}",
year = "1998",
language = "English (US)",
volume = "33",
pages = "534--557",
journal = "Formulary",
issn = "1082-801X",
publisher = "Advanstar Communications",
number = "6",

}

TY - JOUR

T1 - Class I and III antiarrhythmic drugs

T2 - Practical considerations for safe, effective use

AU - Jahangir, Arshad

AU - Stanton, Marshall S.

AU - Hammill, Stephen C.

AU - Shen, Win Kuang

PY - 1998

Y1 - 1998

N2 - Pharmacologic therapy continues to play an important role in the management of cardiac arrhythmias. Choosing an antiarrhythmic agent involves understanding the concepts related to arrhythmogenesis, risk stratification of patients, and antiarrhythmic mechanisms as well as the pharmacokinetics and pharmacodynamics of individual antiarrhythmic agents. This review focuses on some practical issues related to antiarrhythmic pharmacologic therapy with individual class I and class III antiarrhythmic agents currently in clinical use in the United States.

AB - Pharmacologic therapy continues to play an important role in the management of cardiac arrhythmias. Choosing an antiarrhythmic agent involves understanding the concepts related to arrhythmogenesis, risk stratification of patients, and antiarrhythmic mechanisms as well as the pharmacokinetics and pharmacodynamics of individual antiarrhythmic agents. This review focuses on some practical issues related to antiarrhythmic pharmacologic therapy with individual class I and class III antiarrhythmic agents currently in clinical use in the United States.

UR - http://www.scopus.com/inward/record.url?scp=0032450430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032450430&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0032450430

VL - 33

SP - 534

EP - 557

JO - Formulary

JF - Formulary

SN - 1082-801X

IS - 6

ER -